Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Fiest, Kirsten M.
Greenfield, Jamie
Metz, Luanne M.
Patten, Scott B.
Jetté, Nathalie
and
Marrie, Ruth Ann
2017.
Discriminative ability of quality of life measures in multiple sclerosis.
Health and Quality of Life Outcomes,
Vol. 15,
Issue. 1,
Garcia, Diamond
Ledesma, Jason
Berube, Kristen
Valdez, Sarah
Tamrazian, Eric
and
Mehta, Bijal
2019.
Quality of life differences between African Americans and Hispanic Americans with multiple sclerosis.
Multiple Sclerosis and Demyelinating Disorders,
Vol. 4,
Issue. 1,
Boyko, O.V.
Choroshilova, I.I.
Petrov, S.V.
Melnikov, M.V.
and
Boyko, A.N.
2019.
Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab.
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
Vol. 119,
Issue. 10,
p.
120.
Boyko, O.V.
Choroshilova, I.I.
Petrov, S.V.
Melnikov, M.V.
and
Boyko, A.N.
2019.
Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab.
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
Vol. 119,
Issue. 10,
p.
120.
Vlasov, Ya. V.
Polyarnaya, N. G.
and
Boyko, A. N.
2021.
Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis.
Neurology, Neuropsychiatry, Psychosomatics,
Vol. 13,
Issue. 1S,
p.
39.